- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hanmi Pharm Co Ltd (128940)
Hanmi Pharm Co Ltd stock price live, this page displays KS 128940 stock exchange data. View the 128940 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hanmi Pharm Co Ltd real time stock price chart below.
What Is the Hanmi Pharm Co Ltd Stock Price Today?
The Hanmi Pharm Co Ltd stock price today is 285,500.
What Is the Stock Symbol for Hanmi Pharm Co Ltd?
The stock symbol for Hanmi Pharm Co Ltd is "128940."
What Stock Exchange Does Hanmi Pharm Co Ltd Trade On?
Hanmi Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Hanmi Pharm Co Ltd a Good Stock to Buy?
Determining whether Hanmi Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 128940 quote. (ISIN: KR7128940004)
What Is the Hanmi Pharm Co Ltd Stock Price Today?
The Hanmi Pharm Co Ltd stock price today is 285,500.
What Is the Stock Symbol for Hanmi Pharm Co Ltd?
The stock symbol for Hanmi Pharm Co Ltd is "128940."
What Stock Exchange Does Hanmi Pharm Co Ltd Trade On?
Hanmi Pharm Co Ltd is listed and trades on the Seoul stock exchange.
Is Hanmi Pharm Co Ltd a Good Stock to Buy?
Determining whether Hanmi Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 128940 quote. (ISIN: KR7128940004)
Seoul
Currency in KRW
285,500
-500(-0.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
283,000
287,500
52 wk Range
214,500
375,000
128940 Scorecard
Full Analysis
Has raised its dividend for 8 consecutive years
128940 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
283,000287,500
52 wk Range
214,500375,000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
128940 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
361,333
Upside
+26.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Hanmi Pharm Co Ltd Company Profile
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company’s products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
Compare 128940 to Peers and Sector
Metrics to compare | 128940 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship128940PeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.2x | 11.7x | −0.5x | |
PEG Ratio | −1.07 | 0.01 | 0.00 | |
Price/Book | 3.2x | 1.1x | 2.6x | |
Price / LTM Sales | 2.4x | 0.7x | 3.1x | |
Upside (Analyst Target) | 26.1% | 35.2% | 46.1% | |
Fair Value Upside | Unlock | 10.5% | 6.9% | Unlock |
Analyst Ratings
15 Buy
0 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 361,333
(+26.56% Upside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
3,360.00 / 4,254.00
Revenue / Forecast
390.90B / 408.82B
FAQ
What Is the Hanmi Pharm Co (128940) Stock Price Today?
The Hanmi Pharm Co stock price today is 285,500.00
What Stock Exchange Does Hanmi Pharm Co Trade On?
Hanmi Pharm Co is listed and trades on the Seoul Stock Exchange stock exchange.
What Is the Stock Symbol for Hanmi Pharm Co?
The stock symbol for Hanmi Pharm Co is "128940."
Does Hanmi Pharm Co Pay Dividends? What’s The Current Dividend Yield?
The Hanmi Pharm Co dividend yield is 0.44%.
What Is the Hanmi Pharm Co Market Cap?
As of today, Hanmi Pharm Co market cap is 3.62T.
What Is Hanmi Pharm Co's Earnings Per Share (TTM)?
The Hanmi Pharm Co EPS (TTM) is 8,589.65.
When Is the Next Hanmi Pharm Co Earnings Date?
Hanmi Pharm Co will release its next earnings report on 12 Aug 2025.
From a Technical Analysis Perspective, Is 128940 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Hanmi Pharm Co Stock Split?
Hanmi Pharm Co has split 15 times.
How Many Employees Does Hanmi Pharm Co Have?
Hanmi Pharm Co has 2330 employees.
What is the current trading status of Hanmi Pharm Co (128940)?
As of 12 Jul 2025, Hanmi Pharm Co (128940) is trading at a price of 285,500.00, with a previous close of 286,000.00. The stock has fluctuated within a day range of 283,000.00 to 287,500.00, while its 52-week range spans from 214,500.00 to 375,000.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.